COVID-19: Indian Drugmaker Biological E Signs Deal With J&J, Houston College For Vaccine Production

Supported by

Hyderabad-based Biological E has signed two agreements for the development of novel Coronavirus vaccines, one with Janssen Pharmaceutica NV, which is a part of drug giant Johnson & Johnson, and with Houston-based Baylor College of Medicine.

It is the second pharmaceutical company in India to announce the agreements on developing the vaccines after Pune-based Serum Institute Of India that entered into similar agreements with AstraZeneca, which is developing a vaccine with Oxford University.

As a part of the deal, J&J will be transferring technology for manufacturing its vaccine. Biological E will begin production of the drug substance used in Johnson & Johnson’s COVID-19 vaccine candidate that is in early to mid-stage trials, Reuters reported.

The drug giant aims to develop more than a billion doses of its vaccine candidate ‘ Ad26.COV2-S’. Currently, it is in combined Phase 1 and 2 of human trials and expects to enter Phase 3 by the month of September in view of making the vaccine available by next year.

In the second agreement the Hyd- based company has licensed the vaccine produced by the college, which is presently in its pre-clinical trials. According to the agreement, Biological E will manufacture the vaccine, and will collaborate on its further development, The Indian Express reported.

‘The production of the vaccine at Biological E could facilitate its deployment in India and other middle and low-income countries,’ the company’s statement as quoted.

Other Indian companies developing or manufacturing potential COVID-19 vaccines include the Serum Institute, Wockhardt Ltd, Cadila Healthcare Ltd and Panacea Biotec Ltd.

On Thursday, India reported a record daily jump of 67,000 coronavirus infections, taking its total to nearly 2.4 million, having the third-largest number of cases after the United States and Brazil.

Also Read: Former Congress Corporator Among 60 More Arrested In Bengaluru Riots Connection

#PoweredByYou We bring you news and stories that are worth your attention! Stories that are relevant, reliable, contextual and unbiased. If you read us, watch us, and like what we do, then show us some love! Good journalism is expensive to produce and we have come this far only with your support. Keep encouraging independent media organisations and independent journalists. We always want to remain answerable to you and not to anyone else.

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

Amplified by

P&G Shiksha

P&G Shiksha Turns 20 And These Stories Say It All

Amplified by

Isha Foundation

Sadhguru’s Meditation App ‘Miracle of Mind’ Hits 1 Million Downloads in 15 Hours, Surpassing ChatGPT’s Early Growth

Recent Stories

40 Minutes for 3 Km: Bengaluru Man’s Traffic Struggle Goes Viral, Netizens Say ‘Better Finish Lunch and Login’

Trump-Backed Senate Bill Pushes 500% Tariffs on Russia’s Oil Buyers; India & China in the Crosshairs

Denied Tree-Cutting Permit, Bihar Authorities Build ₹100 Crore Road Curving Around Trees

Contributors

Writer : 
Editor : 
Creatives :